Abstract: Elevated C-reactive protein (CRP) levels have previously been described before the onset of type 1 diabetes and gestational diabetes. We hypothesized that inflammation, as reflected by elevated CRP levels, can help predict development of islet autoimmunity or type 1 diabetes. The outcome of this research is to establish potential determinants of raised CRP concentrations in type 1 diabetic patients. Sensitive assay showed 'low-level' CRP concentrations in 147 type 1 patients (83M, 64F, median age 30 years, range 13-67). We have done step by step variant examination to relate these CRP levels to known cardiovascular risk factors and demographic data. Only four patients had established Coronary Heart Disease (median CRP 3.43 mg/l vs. 0.85 mg/l, p=0.035). In subjects without overt CHD, multivariate analysis revealed increase in subject age (p=0.0027), BMI (p=0.001) and HbA1 (p=0.013) to be associated with a higher CRP concentration, as was female sex (p=0.025) and a history of CHD in a first-degree relative (p=0.018, n=58). Elevated CRP levels were positively associated with cardiovascular and renal risk factors: age, body mass index, blood pressure, serum cholesterol level, smoking, plasma glucose level and elevated urinary albumin excretion and presence of hypertension were unrelated. This research work advises that certain of the risk factors connected with CHD in type 1 patients are also individually predictive of high CRP concentrations. The reasons for this, and whether intervention would prove valuable, require further analysis
Introduction
Cardiovascular disease is the main cause of morbidity and mortality in patients with diabetes due to atherosclerosis. The reason for this increase in atherosclerosis is multifactorial, but is in excess of that which would be expected when account is taken of traditional coronary heart disease (CHD) risk factors such a smoking, hyperlipidaemia and hypertension. (Kannel et al. 1979; Stamler et al.1993 ; Adlerberth et al. 1998 Yudkin et al. 1996 . The prevalence of type 2 diabetes has been rapidly rising worldwide, that is a metabolic disease with inappropriate hyperglycemia either due to deficiency of insulin secretion or reduction in the biologic effectiveness of insulin. Elevated inflammatory marker, and altered adipokine concentrations have been observed in obese type 2 diabetes patients (Hansen et al. 2010; Myburgh et al., 2018) . Although the main physiological abnormalities in type 2 diabetic are insulin resistance and impaired insulin secretion (Bergman 1989) , some studies suggests that inflammation have a crucial intermediary role in pathogenesis of type 2 diabetic, thereby linking diabetes with a number of commonly coexisting conditions thought to originate through inflammatory mechanisms (Festa et al 2000) . Atherosclerosis has been described as an inflammatory disease (Ross 1999 ).
Measurement of the acute-phase reactant C-reactive protein (CRP) has been routinely used to detect and monitor inflammatory changes in patients with sepsis or connective tissue diseases. Recently, the use of highly sensitive assays has indicated that variations of CRP within the 'normal range' i.e. <5 mg/l, are a potent risk indicator for CHD in non-diabetic subjects. (Kuller et al., 1996; Ridker et al., 1997; Haverkate et al., 1997) CRP has recently been introduced in cardiovascular medicine as a predictor of myocardial infarction, stroke and peripheral artery disease in different populations (Ridker et al., 1998; Strandberg et al., 1998) . Among pro-inflammatory markers, CRP a sensitive physiological markers of subclinical systemic inflammation, is associated with hyperglycemia, insulin resistance, and overt type 2 diabetic . CRP is a main inflammatory factor that is produced by the liver during acute infection or inflammation and its concentration in plasma can increase as much as 1000-fold during injury and infection (Schultz and Arnold 1990) . Intervention may also be successful in reducing CRP levels 10 and coronary events (Ridker et al., 1997; Ridker et al., 1998 
Material and Methods

Blood sampling
The .99 kg/m2) were included in the study. Hypertension was defined as having a systolic blood pressure ≥140 mmHg and/or a diastolic blood pressure ≥90 mmHg. According to a self-administrated questionnaire, patient's with a history of malignancy, liver disease, untreated hypothyroidism, alcohol abuse, inter current diseases or use of lipid-lowering drugs was excluded from the study. The cutpoints of serum total cholesterol (TC), HDL and LDL Cholesterol (LDL-C) and serum triglycerides (TG) distributions used to assign subjects at different levels of risk were obtained from the NCEP guidelines in the United States (Adult Treatment Panel III).
Patients with type 1 diabetes (n=147, 83M, 64F, median age 35 years) attending the Diabetes Unit, and approval by the local Ethical Committee were studied. None had overt evidence of infection or connective tissue diseases, and all participants had negative urinalysis for nitrite and leukocytes. All patients also had a baseline ECG performed at the time of diagnosis or referral if aged >35 years. Each had low-level CRP measured using a modified latex-enhanced immunoturbimetric assay (Thermo Fisher Scientific, India). Betweenbatch precision (CV) for the assay was 5.6%, 6.9% and 8.2% at CRP concentrations of 5.3, 2.2 and 1.0 mg/l, respectively. The locally-derived median reference value was 0.73 mg/l (0.95 interfractile reference interval 0.2-6.4 mg/l, n=77). Log10 CRP in the patients without known CHD was related by univariate regression and by forward stepwise multiple regression to the following variables: age, sex, duration of diabetes, presence of microvascular complications (retinopathy defined as early background diabetic retinopathy or worse when examined by an experienced examiner using direct ophthalmoscopy through dilated pupils; known microalbuminuria defined as a consistent overnight timed urine albumin excretion rate >20 mg/min, neuropathy defined as peripheral neuropathy using DCCT clinical criteria12), body mass index (kg/m2), current HbA1, current smoking status, current spot early-morning urine micro albumin concentration (mg/l), current non-fasting cholesterol/triglyceride/HDLcholesterol, hypertension (on treatment or current blood pressure >140/90) and first-degree family history of cardiovascular disease. Table 1 lists the characteristics of the diabetic patients who participated in the study. Figure 1 shows the log-normal distribution of CRP values found in these patients. Only six patients had overt CHD (Table 1) . In these patients CRP concentrations were higher than in unaffected patients (median CRP 3.41 mg/l vs. 0.85 mg/l, p=0.035 using Mann-Whitney). While (Table 2 and Table 3) shows those, which remain significantly associated with log10CRP when the data is subjected to a forward stepwise multivariate regression Table 3 . Joint effects of C-reactive protein and risk factors on the relative risk of diminished filtration
Results
Odds ratios (95% CI) are adjusted for age and gender in models. The cut-off point of glucose is based on the 75 th percenti
Discussion
Independent studies have shown that the measurement of baseline concentrations of CRP as a marker of systemic inflammation can predict the risk of future myocardial infarction in non-diabetic subjects (Kuller et al., 1996; Ridker et al., 1998). It is thought that this theory of low-grade inflammation and atherosclerosis could therefore bring together, in one unifying hypothesis, the apparently disparate cardiovascular risk markers of fibrinogen, ferritin and white blood cell count, since they are all acute-phase reactants. Our study has sought to establish some of the determinants of raised CRP concentrations in type 1 diabetic patients (Ridker et al., 1998; Cleland et al. 2000) . The measurements which are predictive of a raised CRP concentration. These findings are in agreement with previous studies involving only non diabetic subjects. (Mendall et al. 1996; Pradhan et al. 2001) Additionally, female sex, a family history of cardiovascular disease and a high current glycated haemoglobin value are also related to rises in CRP. However, when these factors are adjusted for each other by stepwise multiple regression, only the variables in Table 3 (age, sex, family history of CHD, BMI and current HbA1) are found to be independently associated with CRP concentrations. Growing body of evidence implicating low-grade inflammation as a potential dynamic in the pathogenesis of type 2 diabetes. Potential mechanisms for this relationship may be direct or indirect. For example, cytokines such elevated levels of IL-6, which is known to be a main stimulator of the production of most acute-phase proteins, were shown to increase the risk of diabetes (Thorand et al. 2003 ) Type 1 diabetes is now accepted to be a chronic immune-inflammatory disorder. Because it is a disease of inflammation-both of the innate and adaptive immune systems-it is perhaps not surprising that elevated CRP levels were found. It is important to note that the elevated CRP levels were found before elevated glucose levels, so that this marker of inflammation is not related to hyperglycemia. This observation is impossible to study in people who already have type 1 diabetes (Tooke 1999; Nakanishi et al., 2003; King et al., 2003) (Fig. 1) .
Fig. 1 C-Reactive Protein Attention in Diabetic Patients
The female/male difference may simply be associated with an increased prevalence of subclinical urinary infection in (Fig.2) .
Fig. 2 CRP Pathways
Low-level CRP measurements in this situation may thus partly be a surrogate marker for circulating TNFα concentrations. Studies in non-diabetic subjects have shown that aspirin and statin treatment specifically reduce the increased cardiovascular risk associated with high CRP values. (Ridker et al., 1997 ) If applied to the asymptomatic diabetic patients in our study, it would suggest that it is the older, female, poorly controlled, overweight patient with a bad family history of heart disease who is most likely to benefit from such treatment, since they tend to have the highest CRP levels (O'Sullivan et al., 2013; Keevil et al., 1998)
Conclusion
In summary, this study has found that factors already known to be associated with cardiovascular risk in type 1 diabetes are also indicative of raised CRP concentrations. However, the mechanisms involved in these relationships require further investigation
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